Showing results (791-800 of 895) with videos related to

Sort By:
Pageof 90
Cell Death & Disease|March 31, 2019
Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastomaTanwir Hasan, Seamus P Caragher, Jack M Shireman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 15, 2021
First-in-human neuroimaging of soluble epoxide hydrolase using [18F]FNDP PETJennifer M Coughlin, Stephanie Slania, Yong Du, et al.
Journal of Neuro-Oncology|July 24, 2024
The CCL2-CCR4 axis promotes Regulatory T cell trafficking to canine glioma tissuesW K Panek, R G Toedebusch, B E Mclaughlin, et al.
Science Translational Medicine|August 28, 2020
BET inhibition increases βIII-tubulin expression and sensitizes metastatic breast cancer in the brain to vinorelbineDeepak Kanojia, Wojciech K Panek, Alex Cordero, et al.
The Journal of Open Source Education|February 28, 2022
Developing and deploying an integrated workshop curriculum teaching computational skills for reproducible researchZena Lapp, Kelly L Sovacool, Nick Lesniak, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 18, 2019
Activation of Dopamine Receptor 2 Prompts Transcriptomic and Metabolic Plasticity in GlioblastomaSeamus P Caragher, Jack M Shireman, Mei Huang, et al.
Research Square|July 1, 2024
The CCL2-CCR4 Axis Promotes Regulatory T Cell Trafficking to Canine Glioma TissuesW K Panek, R G Toedebusch, B E Mclaughlin, et al.
Journal of Neurosurgery|April 20, 2006
The human survivin promoter: a novel transcriptional targeting strategy for treatment of gliomaWinan J Van Houdt, Yosef S Haviv, Baogen Lu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 9, 2014
Blood-brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imagingYu Cheng, Qing Dai, Ramin A Morshed, et al.
Journal for Immunotherapy of Cancer|February 9, 2023
IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBMMarkella Zannikou, Joseph T Duffy, Rebecca N Levine, et al.
Pageof 90